Identification | Back Directory | [Name]
Timigutuzumab | [CAS]
1665274-14-5 | [Synonyms]
Timigutuzumab Timigutuzumab (anti-ERBB2) Research Grade Timigutuzumab Research Grade Timigutuzumab (DHC09605) |
Hazard Information | Back Directory | [Uses]
Timigutuzumab (GEXMab73) is a humanized monoclonal antibody that targets ErbB2. Timigutuzumab can be used for the research of cancer[1]. | [References]
[1] Santis RD. Anti-ErbB2 immunotherapeutics: struggling to make better antibodies for cancer therapy. MAbs. 2020 Jan-Dec;12(1):1725346. DOI:10.1080/19420862.2020.1725346 |
|
Company Name: |
Biolab Reagents
|
Tel: |
18108604356 18108604356 |
Website: |
www.biolabreagent.com/ |
Company Name: |
Cell Sciences
|
Tel: |
9785721070 |
Website: |
www.cellsciences.com |
|